Experimental validation of a fragment library for lead discovery using SPR biosensor technology
- PMID: 21149860
- DOI: 10.1177/1087057110389038
Experimental validation of a fragment library for lead discovery using SPR biosensor technology
Abstract
A new fragment library for lead discovery has been designed and experimentally validated for use in surface plasmon resonance (SPR) biosensor-based screening. The 930 compounds in the library were selected from 4.6 million commercially available compounds using a series of physicochemical and medicinal chemistry filters. They were screened against 3 prototypical drug targets: HIV-1 protease, thrombin and carbonic anhydrase, and a nontarget: human serum albumin. Compound solubility was not a problem under the conditions used for screening. The high sensitivity of the sensor surfaces allowed the detection of interactions for 35% to 97% of the fragments, depending on the target protein. None of the fragments was promiscuous (i.e., interacted with a stoichiometry ≥5:1 with all 4 proteins), and only 2 compounds dissociated slowly from all 4 proteins. The use of several targets proved valuable since several compounds would have been disqualified from the library on the grounds of promiscuity if fewer target proteins had been used. The experimental procedure allowed an efficient evaluation and exploration of the new fragment library and confirmed that the new library is suitable for SPR biosensor-based screening.
Similar articles
-
Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process.Future Med Chem. 2009 Nov;1(8):1399-414. doi: 10.4155/fmc.09.100. Future Med Chem. 2009. PMID: 21426056
-
Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.J Biomol Screen. 2010 Sep;15(8):978-89. doi: 10.1177/1087057110375614. J Biomol Screen. 2010. PMID: 20817886
-
Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library.J Med Chem. 2008 Jun 26;51(12):3449-59. doi: 10.1021/jm8000289. J Med Chem. 2008. PMID: 18494455
-
Emerging role of surface plasmon resonance in fragment-based drug discovery.Future Med Chem. 2011 Oct;3(14):1809-20. doi: 10.4155/fmc.11.128. Future Med Chem. 2011. PMID: 22004086 Review.
-
SPR-based fragment screening: advantages and applications.Curr Top Med Chem. 2007;7(16):1630-42. doi: 10.2174/156802607782341073. Curr Top Med Chem. 2007. PMID: 17979772 Review.
Cited by
-
Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond.J Med Chem. 2021 Apr 22;64(8):4333-4358. doi: 10.1021/acs.jmedchem.0c01686. Epub 2021 Apr 12. J Med Chem. 2021. PMID: 33844535 Free PMC article.
-
New agents for the treatment of drug-resistant Mycobacterium tuberculosis.Adv Drug Deliv Rev. 2016 Jul 1;102:55-72. doi: 10.1016/j.addr.2016.04.026. Epub 2016 May 2. Adv Drug Deliv Rev. 2016. PMID: 27151308 Free PMC article. Review.
-
High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.Curr Top Med Chem. 2015;15(20):2032-42. doi: 10.2174/1568026615666150519102459. Curr Top Med Chem. 2015. PMID: 25986689 Free PMC article. Review.
-
NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.Chem Rev. 2014 May 14;114(9):4749-63. doi: 10.1021/cr500043b. Epub 2014 Apr 8. Chem Rev. 2014. PMID: 24712885 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
